Episode 12.10 The New Science of Hyperemesis and More!
57 min
We revisit standout ABOG reading-list studies and use them to stress-test common clinical theories against real-world evidence. Along the way, we unpack a major hyperemesis gravidarum finding that could reshape how we counsel patients and how future treatments get built. Featuring Jamie Perry, MD. • how Bulkamid urethral bulking stacks up against TVT sling surgery at five years for stress urinary incontinence • why crossover and intent-to-treat analysis change how you interpret “cure” and satisfaction • why metronidazole after endometriosis excision does not improve persistent postoperative pain • how microbiome narratives can sound airtight while still failing in clinical trials • why ibuprofen appears safe postpartum for severe hypertensive disorders of pregnancy compared with acetaminophen • how Doppler tools like CPR help stratify late fetal growth restriction and guide timing of delivery • what the GDF-15 story suggests about hyperemesis risk, fetal-placental signaling, and future therapies • how to think about low-dose estrogen contraception in adolescents, bone mineral density accrual, and what guidelines actually say 0:00 Welcome And Lazy November Plan 2:00 Bulkamid Versus TVT For SUI 9:26 Metronidazole After Endometriosis Excision 17:29 Ibuprofen Safety After Severe Preeclampsia 21:56 Ultrasound Risk Tools For Late FGR 29:45 GDF-15 And Hyperemesis Breakthrough 46:33 Low Dose Estrogen Pills And Bones 57:08 Final Takeaways And Where To Follow Be sure to check out thinking about obgyn.com for more information and be sure to follow us on Instagram. Follow us on Instagram @thinkingaboutobgyn.